Cross-Sectional Survey on the Current Role of Clinical Pharmacists among Antimicrobial Stewardship Programmes in Catalonia: Much Ado about Nothing.

Background: Antimicrobial resistance killed 1.27 million people in 2019, so urgent actions are desperately needed. Antimicrobial stewardship programmes (ASPs) are essential to optimize antimicrobial use.

Impact of drug safety warnings and antimicrobial stewardship programme implementation on tigecycline prescribing: a prospective quasi-experimental interrupted time series analysis.

Background: Tigecycline is the first member of the glycylcyclines. Both the FDA (2010 and 2013) and the EMA (2011) issued safety warnings describing an increased mortality risk associated with tigecycline compared with other antibiotics treating severe infections. One of the best strategies to optimize antimicrobial therapies is through the establishment of antimicrobial stewardship programmes (ASPs) in hospitals.

Bisphosphonate-induced cutaneous adverse events: the difficulty of assessing imputability through patch testing.

Background: Cutaneous adverse drug reactions (CADRs) due to bisphosphonates (BPs) have been scarcely described in the literature.

Objective: To discuss the diagnostic value and limitations of cutaneous provocation tests with BPs.

Methods: A descriptive case series study with a control group of CADRs due to BPs studied using patch testing from 2005 to 2010 is presented.

[Influence of ethnicity on the pharmacokinetics of amikacin].

Objective: Despite the increasing ethnic diversity, there are few studies of its influence on the pharmacokinetics of amikacin. The objective of this study was to compare the pharmacokinetics of amikacin in different populations: Asian, Hispanic, North Africans and Caucasian.

Methods: A retrospective observational study was performed in a tertiary teaching hospital during eight years.